Literature DB >> 22669756

Considerations of traditional Chinese medicine as adjunct therapy in the management of ulcerative colitis.

Chi Zhang1, Miao Jiang, Aiping Lu.   

Abstract

Ulcerative colitis (UC) has been treated with traditional Chinese medicine (TCM) for literally thousands of years. This paper gives an overview of TCM in the management of UC, provides an account of the state of the evidence, identifies gaps in the research base, and makes recommendations for future research. TCM is based on patterns and this influences the selection of the type of herbal medication or manipulation technique used for treatment. The majority of clinical studies on the efficacy of Chinese herbal medicine and acupuncture in the treatment of UC have methodological shortcomings. The extent of heterogeneity in many of these clinical trials, poor design quality of past studies prevent meaningful systematic reviews (SRs) or meta-analysis, although there are positive signs that TCM may be useful in relieving abdominal pain and reducing inflammation. Many unknowns still exist, including the active ingredients within Chinese herbal medicine and the potential for interaction with other drugs or western medications. While there may be a potential role for utilizing TCM in the treatment of UC patients relying on both traditional concepts and modern developments, it should be recognized that there are no studies that irrefutably support the use of TCM in the treatment of UC. Further basic or translational research must be done to elucidate mechanisms of action of these agents, and well-designed and well-conducted clinical studies must also be done to determine efficacy and safety of these agents.

Entities:  

Mesh:

Year:  2013        PMID: 22669756     DOI: 10.1007/s12016-012-8328-9

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  45 in total

Review 1.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

2.  [Current status and problems in developing clinical guidelines for Chinese medicine and integrative medicine].

Authors:  Ke-Ji Chen; Yue-Rong Jiang
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2009-04

Review 3.  The geoepidemiology of autoimmune intestinal diseases.

Authors:  Ian Logan; Christopher L Bowlus
Journal:  Autoimmun Rev       Date:  2009-11-10       Impact factor: 9.754

4.  [Meta-analysis on acupuncture and moxibustion for treatment of ulcerative colitis].

Authors:  Jing-ping Mu; Huan-gan Wu; Zhi-quan Zhang; Hui-rong Liu; Yi Zhu; Zheng Shi; Xiao-mei Wang
Journal:  Zhongguo Zhen Jiu       Date:  2007-09

5.  Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled study.

Authors:  Stefanie Joos; Nicole Wildau; Ralf Kohnen; Joachim Szecsenyi; Detlef Schuppan; Stefan N Willich; Eckhart G Hahn; Benno Brinkhaus
Journal:  Scand J Gastroenterol       Date:  2006-09       Impact factor: 2.423

Review 6.  Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?

Authors:  Karen H Costenbader; Steffen Gay; Marta E Alarcón-Riquelme; Luca Iaccarino; Andrea Doria
Journal:  Autoimmun Rev       Date:  2011-10-25       Impact factor: 9.754

7.  An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease.

Authors:  P Rawsthorne; F Shanahan; N C Cronin; P A Anton; R Löfberg; L Bohman; C N Bernstein
Journal:  Am J Gastroenterol       Date:  1999-05       Impact factor: 10.864

8.  [Use and acceptance of classical natural and alternative medicine in Germany--findings of a representative population-based survey].

Authors:  U Härtel; E Volger
Journal:  Forsch Komplementarmed Klass Naturheilkd       Date:  2004-12

Review 9.  Biologics - beyond the joints.

Authors:  Zoltán Szekanecz; Sándor Szántó; Zoltán Szabó; Andrea Váncsa; Szilvia Szamosi; Nóra Bodnár; Gabriella Szücs
Journal:  Autoimmun Rev       Date:  2010-08-10       Impact factor: 9.754

10.  Why do patients seek a second opinion or alternative medicine?

Authors:  L R Sutherland; M J Verhoef
Journal:  J Clin Gastroenterol       Date:  1994-10       Impact factor: 3.062

View more
  24 in total

1.  Composite Sophora Colon-Soluble Capsule Ameliorates DSS-Induced Ulcerative Colitis in Mice via Gut Microbiota-Derived Butyric Acid and NCR+ ILC3.

Authors:  Ming-Jun Chen; Yang Feng; Lu Gao; Ming-Xiong Lin; Shi-da Wang; Zhan-Qi Tong
Journal:  Chin J Integr Med       Date:  2022-04-12       Impact factor: 1.978

2.  Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats.

Authors:  Ying Luo; Jiaxian Chen; Yuewu Chen; Yangshen Su; Xiaoyan Wu; Wanling Zheng; Xianxia Liu; Lei Chen
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

3.  Lizhong decoction ameliorates ulcerative colitis in mice via modulating gut microbiota and its metabolites.

Authors:  Junfeng Zou; Yumeng Shen; Mengjun Chen; Zhimiao Zhang; Suwei Xiao; Chen Liu; Yue Wan; Lei Yang; Shu Jiang; Erxin Shang; Dawei Qian; Jinao Duan
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-17       Impact factor: 4.813

4.  Deoxyschizandrin suppresses dss-induced ulcerative colitis in mice.

Authors:  Wen-Feng Zhang; Yan Yang; Xin Su; Da-Yan Xu; Yu-Li Yan; Qiao Gao; Ming-Hua Duan
Journal:  Saudi J Gastroenterol       Date:  2016-11       Impact factor: 2.485

5.  Shen-Ling-Bai-Zhu-San for ulcerative colitis: Protocol for a systematic review and meta-analysis.

Authors:  Long Yang; Yuanyuan Song; Pei Jin; Yueyang Liu; Yue Wang; Huixia Qiao; Yahui Huang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

6.  Kuijieling-Containing Serum Regulates Th17 and Treg Cell Differentiation by Inhibiting STAT3 Signaling In Vitro.

Authors:  Yu Long; Yuqing He; Fengming Jie; Sixin Li; Yanli Wu; Yanwu Li; Qun Du
Journal:  Evid Based Complement Alternat Med       Date:  2019-08-25       Impact factor: 2.629

7.  Addition of Berberine to 5-Aminosalicylic Acid for Treatment of Dextran Sulfate Sodium-Induced Chronic Colitis in C57BL/6 Mice.

Authors:  Yan-hong Li; Man Zhang; Hai-tao Xiao; Hai-bo Fu; Alan Ho; Cheng-yuan Lin; Yu Huang; Ge Lin; Zhao-xiang Bian
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

8.  Modified Sijunzi decoction in the treatment of ulcerative colitis in the remission phase: study protocol for a series of N-of-1 double-blind, randomised controlled trials.

Authors:  Yi-Ming Chen; Jie-Min Deng; Yi Wen; Bin Chen; Jiang-Tao Hou; Bin Peng; Shi-Jing Zhang; Hong Mi; Qi-Long Jiang; Xia-Lin Wu; Feng-Bin Liu; Xin-Lin Chen
Journal:  Trials       Date:  2020-05-12       Impact factor: 2.279

9.  Systems pharmacology reveals the unique mechanism features of Shenzhu Capsule for treatment of ulcerative colitis in comparison with synthetic drugs.

Authors:  Wuwen Feng; Hui Ao; Shijun Yue; Cheng Peng
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

10.  Effects of Jian Pi Qing Chang Hua Shi decoction on mucosal injuries in a 2,4,6-trinitrobenzene sulphonic acid-induced inflammatory bowel disease rat model.

Authors:  Huicun Zhang; Na Ta; Hong Shen; Hongbing Wang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.